Koninklijke Philips | PHG - Equity Capital And Reserves


Koninklijke Philips reported EUR12.87B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Baxter International USD 6.04B 86M Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Boston Scientific USD 25.86B 1.63B Mar/2026
Danaher USD 52.95B 415M Mar/2026
Demant DKK 9.84B 446M Dec/2025
Dexcom USD 2.96B 210.9M Mar/2026
Edwards Lifesciences USD 10.33B 10.1M Mar/2026
Fresenius EUR 19.77B 1.14B Dec/2025
General Electric Aerospace USD 18.06B 841M Mar/2026
Getinge SEK 33.01B 2.75B Dec/2024
Globus Medical USD 4.73B 159.06M Mar/2026
GN Store Nord DKK 10.12B 4.76B Mar/2026
Hitachi JPY 6.57T 211.91B Mar/2026
Idexx Laboratories USD 1.56B 49.28M Mar/2026
Insulet USD 1.3B 212.6M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
Intuitive Surgical USD 17.47B 349.5M Mar/2026
J&J USD 81.19B 358M Mar/2026
Koninklijke Philips EUR 12.87B 489.5M Dec/2025
Masimo USD 788.9M 67.7M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Philips EUR 11.39B 403M Mar/2026
ResMed USD 6.49B 171.03M Mar/2026
Smith & Nephew USD 5.54B 331M Dec/2025
Steris USD 7.18B 29.1M Mar/2026
Stryker USD 22.42B 635M Dec/2025
Teleflex USD 3.08B 40.33M Mar/2026
Terumo JPY 1.58T 62.18B Mar/2026
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026